XANAX Safety Questions, XANAX Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about XANAX. Our extensive database of XANAX adverse events and XANAX warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about XANAX

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet




XANAX Safety Reports

Total XANAX reports: 215.
XANAX FDA safety alerts: 2002 2007 .
Reported deaths: 20    Reported hospitalizations: 89.
Take XANAX Side Effects Survey or Share Your XANAX Story. XANAX Usage.

< Previous  Showing 151-215 of 215

Consumer or non-health professional from UNITED STATES reported XANAX problem on Oct 13, 2006. Female patient, weighting 135.0 lb, was diagnosed with bipolar disorder and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: activities of daily living impaired, ageusia, agitation, agoraphobia, anger, anxiety, apathy, arthralgia, bladder disorder. XANAX dosage: unknown. Patient recovered.

XANAX problem was reported by a Health Professional from UNITED STATES on Oct 27, 2006. Female patient, 48 years of age, weighting 130.0 lb, was diagnosed with anosmia and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: activities of daily living impaired, ageusia, amnesia, anosmia, blood pressure immeasurable, incoherent, malaise. XANAX dosage: TAPERING DOWN EACH DAY BY 1ML 3 TIMES A DAY BUCCAL. During the same period patient was treated with ZITHROMAX, ZICAM. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported XANAX problem on Oct 16, 2006. Male patient, 49 years of age, was diagnosed with insomnia, nasopharyngitis and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. XANAX dosage: unknown. During the same period patient was treated with ROBITUSSIN. Patient died on 09/17/2006.

XANAX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 27, 2006. Female patient was diagnosed with insomnia and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: ankle fracture, fall, fractured sacrum. XANAX dosage: unknown. During the same period patient was treated with AMBIEN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported XANAX problem on Oct 23, 2006. Female patient, 35 years of age, weighting 266.0 lb, was diagnosed with anxiety, panic attack and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: bedridden, benign breast neoplasm, bone pain, convulsion, neuropathy peripheral, paraesthesia, paralysis, walking aid user. XANAX dosage: unknown. During the same period patient was treated with ADAVIN, TENORMIN, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

XANAX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 25, 2006. Female patient, 42 years of age, weighting 130.0 lb, was diagnosed with panic attack, sleep disorder, neuralgia, pain and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: fatigue, insomnia, neuralgia, neuropathy, peripheral nerve operation, procedural pain, restlessness. XANAX dosage: unknown. During the same period patient was treated with LYRICA, AMITRIPTYLINE HYDROCHLORIDE, PERCOCET. Patient recovered.

Consumer or non-health professional from UNITED STATES reported XANAX problem on Oct 25, 2006. Male patient, 62 years of age, weighting 200.0 lb, was diagnosed with anxiety and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, blood magnesium decreased, blood potassium decreased, dizziness. XANAX dosage: 40 MG (20 MG, 2 IN 1 D). Patient was hospitalized. Patient recovered.

XANAX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 25, 2006. Male patient, 47 years of age, was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: aggression, amnesia, anaemia, anxiety, bipolar i disorder, depression, dysphagia, hypertension. XANAX dosage: unknown. During the same period patient was treated with PAXIL, ACETAMINOPHEN, BUSPIRONE, LORAZEPAM, CLONAZEPAM, RAMIPRIL. Patient was hospitalized and became disabled. Patient recovered.

Consumer or non-health professional from UNITED STATES reported XANAX problem on Dec 16, 2005. Female patient, 72 years of age, was diagnosed with insomnia and was treated with XANAX. XANAX dosage: unknown. During the same period patient was treated with COUMADIN, AMBIEN. Patient died on 01/05/2006.

XANAX problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 07, 2006. Male patient, 60 years of age, weighting 231.0 lb, was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: condition aggravated, diabetes mellitus, lung neoplasm malignant. XANAX dosage: unknown. During the same period patient was treated with LASIX, ZYPREXA. Patient was hospitalized. Patient died on 09/19/2005.

Consumer or non-health professional from UNITED STATES reported XANAX problem on Nov 01, 2006. Female patient, 65 years of age, weighting 111.0 lb, was diagnosed with depression and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: asthenia, fall, loss of consciousness. XANAX dosage: 0.5 MG (0.5 MG, 1 IN 1 D), ORAL. During the same period patient was treated with ALBUTEROL, SINGULAIR, PREDNISONE. Patient recovered.

XANAX problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 04, 2006. Female patient, 26 years of age, weighting 348.0 lb, was diagnosed with anxiety, insomnia, convulsion and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: bipolar disorder, convulsion, economic problem, schizophrenia, sleep apnoea syndrome, treatment noncompliance. XANAX dosage: 1 MG (1 MG, 1 IN 1 D). During the same period patient was treated with LYRICA, GABAPENTIN, DEPAKOTE, ZONEGRAN, TRILEPTAL, ZESTRIL, ENALAPRIL MALEATE. Patient recovered.

Health Professional from FRANCE reported XANAX problem on Nov 07, 2006. Female patient, weighting 3.70 lb, was diagnosed with bipolar disorder and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: agitation neonatal, caesarean section, neonatal respiratory distress syndrome, premature baby. XANAX dosage: 0.75 MG (3 IN 1 D), PLACENTAL. During the same period patient was treated with ANAFRANIL, CHLORPROMAZINE, DEPAKOTE, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient recovered.

XANAX problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 06, 2006. Female patient, 50 years of age, weighting 164.0 lb, was diagnosed with anxiety, multiple allergies and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: arthralgia, burning sensation, dyspnoea, muscle spasms, pain, panic attack. XANAX dosage: unknown. During the same period patient was treated with ZYRTEC, VIVELLE, PROGESTERONE, CALCIUM, VITAMIN B CAP, VITAMIN A, VITAMIN E, NEURONTIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported XANAX problem on Nov 15, 2006. Female patient, weighting 118.0 lb, was diagnosed with anxiety and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: back pain, blepharitis, cataract operation, constipation, dacryocystorhinostomy, depression, dry eye, eye infection. XANAX dosage: unknown. During the same period patient was treated with CHANTIX, RESTORIL, PREVACID, PRENATAL VITAMINS. Patient recovered.

XANAX problem was reported by a Physician from UNITED STATES on Nov 14, 2006. Female patient, 59 years of age, weighting 125.0 lb, was diagnosed with anxiety, panic attack and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: activities of daily living impaired, blood pressure increased, dependence, depression, head banging, insomnia, oral intake reduced, screaming. XANAX dosage: 1.5 MG (0.5 MG, 3 IN 1 D); ORAL. During the same period patient was treated with NEURONTIN, LORTAB. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported XANAX problem on Nov 17, 2006. Female patient, 44 years of age, weighting 104.0 lb, was diagnosed with anxiety, depression and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: abdominal pain, decreased appetite, faeces discoloured, hepatic pain, sleep disorder, steatorrhoea, vision blurred. XANAX dosage: unknown. During the same period patient was treated with ZOLOFT. Patient recovered.

XANAX problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 15, 2006. Female patient, 63 years of age, weighting 18.00 lb, was diagnosed with anxiety and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: back pain, blepharitis, cataract operation, constipation, depression, dry eye, eye infection, faeces discoloured. XANAX dosage: unknown. During the same period patient was treated with CHANTIX, RESTORIL, PREVACID, PRENATAL VITAMINS. Patient recovered.

Consumer or non-health professional from UNITED STATES reported XANAX problem on Nov 21, 2006. Female patient, weighting 135.0 lb, was diagnosed with bipolar disorder and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: ageusia, agitation, anger, anxiety, apathy, arthralgia, bladder disorder, bronchitis, confusional state. XANAX dosage: unknown. Patient recovered.

XANAX problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 20, 2006. Male patient, 60 years of age, weighting 160.0 lb, was diagnosed with insomnia and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, incorrect dose administered, muscle twitching, mydriasis, vision blurred. XANAX dosage: 5 MG (5 MG, 1 IN 1 D), ORAL. During the same period patient was treated with EFFEXOR, LEVOTHYROXINE. Patient recovered.

Health Professional from FRANCE reported XANAX problem on Nov 24, 2006. Female patient, 17 years of age, was diagnosed with intentional overdose and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: diarrhoea, vomiting. XANAX dosage: unknown. During the same period patient was treated with PSEUDOEPHEDRINE, ACETAMINOPHEN, IBUPROFEN, SAVARINE, RODOGYL, DICLOFENAC, ACECLOFENAC. Patient was hospitalized. Patient recovered.

XANAX problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 21, 2006. Male patient, 42 years of age, weighting 185.0 lb, was diagnosed with anxiety, panic attack and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: hypersomnia, memory impairment, road traffic accident. XANAX dosage: 6 MG (2 MG, 3 IN 1 D). During the same period patient was treated with CHANTIX, OXYCONTIN, ROXICODONE, CYMBALTA, ATENOLOL, AMBIEN. Patient recovered.

Physician from UNITED STATES reported XANAX problem on Nov 27, 2006. Female patient, 31 years of age, weighting 115.0 lb, was diagnosed with psychogenic pain disorder, temporal lobe epilepsy and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: activities of daily living impaired, aggression, agitation, alcohol use, anterograde amnesia, anxiety, blepharospasm, burning sensation, cognitive disorder. XANAX dosage: unknown. During the same period patient was treated with NEURONTIN, GABITRIL, ADDERALL, LEXAPRO, SYNTHROID, KEPPRA, REMERON. Patient was hospitalized. Patient recovered.

XANAX problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 29, 2006. Female patient, 52 years of age, weighting 175.0 lb, was diagnosed with anxiety, panic disorder and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: suicide attempt. XANAX dosage: unknown. During the same period patient was treated with CRESTOR, SYNTHROID. Patient was hospitalized. Patient recovered.

Health Professional from FRANCE reported XANAX problem on Dec 01, 2006. Male patient, weighting 8.60 lb, was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: agitation neonatal, amniocentesis abnormal, cleft palate, congenital hearing disorder, congenital jaw malformation, hypertonia neonatal. XANAX dosage: 0.5 MG, PLACENTAL. During the same period patient was treated with SUBUTEX, ZOPICLONE. Patient was hospitalized and became disabled. Patient recovered.

XANAX problem was reported by a Physician from UNITED STATES on Dec 08, 2006. Female patient, 35 years of age, weighting 266.0 lb, was diagnosed with panic attack and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: bedridden, bone pain, convulsion, fear, gait disturbance, mobility decreased, neuropathy peripheral, pain in extremity, paralysis. XANAX dosage: unknown. During the same period patient was treated with TENORMIN, TYLENOL, ADAVIN. Patient was hospitalized. Patient recovered.

Physician from SWITZERLAND reported XANAX problem on Dec 08, 2006. Female patient, 35 years of age, was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: blood alcohol increased, hypotension, somnolence. XANAX dosage: unknown. During the same period patient was treated with ZOLOFT, ENTUMIN. Patient was hospitalized. Patient recovered.

XANAX problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 09, 2006. Female patient, 36 years of age, weighting 125.0 lb, was diagnosed with panic attack, ex-smoker and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: anxiety, crying, disease recurrence, feeling abnormal, food craving, loss of employment, nausea, nervousness, paranoia. XANAX dosage: unknown. During the same period patient was treated with CHANTIX, VITAMIN B CAP. Patient recovered.

Pharmacist from UNITED STATES reported XANAX problem on Dec 22, 2006. Male patient, weighting 119.9 lb, was diagnosed with sleep disorder and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: alcohol use, amnesia, contusion, convulsion, dizziness, epistaxis, feeling abnormal, loss of consciousness. XANAX dosage: unknown. Patient was hospitalized. Patient recovered.

XANAX problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 20, 2006. Female patient, weighting 155.0 lb, was diagnosed with nervousness and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased. XANAX dosage: unknown. During the same period patient was treated with CHANTIX, PLAVIX, ASPIRIN, MUSCLE RELAXANTS, HYDROCODONE BITARTRATE, INSULIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported XANAX problem on Dec 12, 2006. Male patient, 47 years of age, was diagnosed with obsessive-compulsive disorder and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: eye burns, eye disorder, maculopathy, retinal anomaly congenital, visual disturbance. XANAX dosage: DAILY DOSE:4.5MG. During the same period patient was treated with ZOLOFT, NORTRIPTYLINE, LORAZEPAM, LUVOX, PAXIL. Patient recovered.

XANAX problem was reported by a Health Professional from UNITED STATES on Dec 15, 2006. Male patient, 56 years of age, was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: priapism. XANAX dosage: unknown. During the same period patient was treated with VERAPAMIL HYDROCHLORIDE CAPLET, TEMAZEPAM, DEPAKOTE. Patient recovered.

Physician from UNITED STATES reported XANAX problem on June 29, 2007. Female patient, 64 years of age, was diagnosed with anxiety, tremor, hypertension and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, constipation, haematochezia, haemorrhoidal haemorrhage, haemorrhoids. XANAX dosage: 1 MG, BID. During the same period patient was treated with POTASSIUM ACETATE, FUROSEMIDE, NEXIUM, FEXOFENADINE HYDROCHLORIDE, LISINOPRIL AND HYDROCHLOROTHIAZIDE, LIPITOR, ZETIA. Patient recovered.

XANAX problem was reported by a Physician from UNITED STATES on July 03, 2007. Female patient, 65 years of age, was diagnosed with anxiety and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: headache, nausea, nightmare, stomach discomfort, tremor. XANAX dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported XANAX problem on June 28, 2007. Male patient, 85 years of age, weighting 145.1 lb, was diagnosed with pain and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: chest discomfort, disorientation, dyspepsia, fatigue. XANAX dosage: unknown. During the same period patient was treated with ALEVE. Patient recovered.

XANAX problem was reported by a Consumer or non-health professional from UNITED STATES on July 09, 2007. Male patient, weighting 225.1 lb, was diagnosed with anxiety and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: accident. XANAX dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from NETHERLANDS reported XANAX problem on June 13, 2007. Female patient, weighting 136.7 lb, was diagnosed with nervousness, dyskinesia and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, cognitive disorder, coordination abnormal, heart rate increased, hypercholesterolaemia, hypertension, motor dysfunction. XANAX dosage: unknown. During the same period patient was treated with CODEINE PHOSPHATE AND ACETAMINOPHEN, ATENOLOL, PAROXETINE, LIPITOR, SOTALOL HYDROCHLORIDE, COZAAR. Patient recovered.

XANAX problem was reported by a Consumer or non-health professional from UNITED STATES on July 10, 2007. Male patient, weighting 125.0 lb, was diagnosed with anxiety, depression and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: amnesia, anxiety, cerebrovascular accident, convulsion, feeling drunk, motor dysfunction, underweight. XANAX dosage: unknown. During the same period patient was treated with AMBIEN, LONOX, DONNATAL, COMPAZINE, DARVOCET. Patient recovered.

Pharmacist from FRANCE reported XANAX problem on July 13, 2007. Male patient, 18 years of age, was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: intentional overdose. XANAX dosage: unknown. Patient recovered.

XANAX problem was reported by a Consumer or non-health professional from UNITED STATES on July 16, 2007. Female patient, weighting 140.0 lb, was diagnosed with anxiety, adrenal disorder and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: herpes zoster, hypotension, loss of consciousness, pituitary-dependent cushing's syndrome, road traffic accident. XANAX dosage: unknown. During the same period patient was treated with METOPROLOL SUCCINATE, NEURONTIN, TOPAMAX, LOTREL, ZETIA, RANITIDINE HYDROCHLORIDE, ANALGESICS. Patient recovered.

Health Professional from FRANCE reported XANAX problem on July 12, 2007. Female patient, 71 years of age, weighting 125.7 lb, was diagnosed with hypertension and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: haemolytic anaemia. XANAX dosage: unknown. During the same period patient was treated with RABEPRAZOLE, BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

XANAX problem was reported by a Consumer or non-health professional from UNITED STATES on July 20, 2007. Female patient, weighting 117.1 lb, was diagnosed with anxiety and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: back pain, blepharitis, cataract operation, cold sweat, constipation, dacryocystorhinostomy, depression, disorientation. XANAX dosage: unknown. During the same period patient was treated with CHANTIX, RESTORIL, PREVACID, PRENATAL VITAMINS, VITAMIN B, VITAMIN D. Patient recovered.

Consumer or non-health professional from UNITED STATES reported XANAX problem on July 16, 2007. Male patient, weighting 218.0 lb, was diagnosed with panic disorder and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: diarrhoea, disorientation, feeling abnormal, glossodynia, incoherent, joint injury, loss of consciousness, malaise, mental impairment. XANAX dosage: unknown. During the same period patient was treated with KLONOPIN, LEXAPRO. Patient was hospitalized. Patient recovered.

XANAX problem was reported by a Physician from UNITED STATES on July 20, 2007. Female patient was diagnosed with panic disorder and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: anxiety, blood pressure increased, dizziness. XANAX dosage: 0.75MG QID PO. During the same period patient was treated with BUSPAR. Patient recovered.

Consumer or non-health professional from UNITED STATES reported XANAX problem on July 24, 2007. Male patient, weighting 156.1 lb, was diagnosed with stress and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: arthropod sting, blood glucose decreased, delirium, loss of consciousness. XANAX dosage: unknown. During the same period patient was treated with DIOVAN, DIGOXIN, ASPIRIN, AMBIEN, CLARITIN, SINGULAIR, CROMOLYN. Patient recovered.

XANAX problem was reported by a Health Professional from FRANCE on July 25, 2007. Female patient, 79 years of age, was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: bradycardia, hyponatraemia, rib fracture, syncope. XANAX dosage: unknown. During the same period patient was treated with PAROXETINE, FUROSEMIDE, NICORANDIL, ASPIRIN, ESOMEPRAZOLE MAGNESIUM. Patient was hospitalized. Patient recovered.

Physician from SWITZERLAND reported XANAX problem on July 26, 2007. Female patient, 65 years of age, was diagnosed with pain and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: c-reactive protein increased, confusional state, hyperpyrexia, hypotension, hypoxia, tachycardia. XANAX dosage: unknown. During the same period patient was treated with BUPRENORPHINE, NEXIUM, PRAVASTATIN, TORSEMIDE, EUTHYROX, ASPIRIN, DAFALGAN. Patient was hospitalized. Patient recovered.

XANAX problem was reported by a Pharmacist from FRANCE on July 31, 2007. Male patient, 27 years of age, weighting 165.3 lb, was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: intentional overdose, suicide attempt. XANAX dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported XANAX problem on Aug 15, 2007. Female patient, 49 years of age, weighting 170.0 lb, was diagnosed with anxiety disorder and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: chest discomfort, tinnitus. XANAX dosage: unknown. During the same period patient was treated with ALPRAZOLAM. Patient recovered.

XANAX problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 09, 2007. Female patient, 56 years of age, was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: suicide attempt. XANAX dosage: unknown. Patient recovered.

Physician from SLOVENIA reported XANAX problem on Aug 09, 2007. Female patient, 50 years of age, was diagnosed with suicidal ideation and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: no adverse reaction, overdose. XANAX dosage: unknown. Patient recovered.

XANAX problem was reported by a Health Professional from UNITED STATES on Aug 13, 2007. Female patient, weighting 188.1 lb, was diagnosed with anxiety, hypertension, depression and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: anxiety, arthritis, arthroscopy, atrioventricular block, back pain, blood cholesterol increased, blood pressure increased, coronary artery bypass, deep vein thrombosis. XANAX dosage: unknown. During the same period patient was treated with ATENOLOL, WELLBUTRIN, AVAPRO. Patient was hospitalized. Patient recovered.

Physician from SLOVENIA reported XANAX problem on Aug 16, 2007. Female patient, 50 years of age, was diagnosed with suicidal ideation and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: no adverse reaction, overdose. XANAX dosage: DAILY DOSE:30MG. Patient recovered.

XANAX problem was reported by a Consumer or non-health professional from CZECH REPUBLIC on Aug 15, 2007. Female patient, 34 years of age, was diagnosed with anxiety, depression and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: anxiety, apathy, feeling of despair, headache, nausea, tension. XANAX dosage: DAILY DOSE:2MG. During the same period patient was treated with ZOLOFT, SEROPRAM, AURORIX, DEPREX, VENLAFAXINE, LERIVON, CIPRALEX. Patient recovered.

Consumer or non-health professional from UNITED STATES reported XANAX problem on Aug 20, 2007. Female patient, weighting 211.0 lb, was diagnosed with bipolar disorder, anxiety and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: dyspnoea, grand mal convulsion. XANAX dosage: unknown. During the same period patient was treated with ZOLOFT, AMBIEN, SPIRIVA, ADVAIR DISKUS, QUINAPRIL, MONTELUKAST, LOVASTATIN. Patient recovered.

XANAX problem was reported by a Health Professional from FRANCE on Aug 22, 2007. Male patient, 48 years of age, was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: coma, haemodialysis, renal failure acute, rhabdomyolysis, tachypnoea. XANAX dosage: unknown. During the same period patient was treated with CYAMEMAZINE. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported XANAX problem on Aug 24, 2007. Male patient, 67 years of age, was diagnosed with insomnia and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: injury, middle insomnia, parasomnia, road traffic accident. XANAX dosage: unknown. During the same period patient was treated with LUNESTA, ALTACE, HYDROCHLOROTHIAZIDE. Patient recovered.

XANAX problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 31, 2007. Male patient, weighting 312.0 lb, was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: anxiety, blood cholesterol increased, cardiac disorder, hypertension, thyroid disorder. XANAX dosage: unknown. During the same period patient was treated with TENORMIN, DYAZIDE, ACIPHEX, SYNTHROID, TRICOR, SEROQUEL. Patient recovered.

Physician from BELGIUM reported XANAX problem on Sept 04, 2007. Female patient, weighting 253.5 lb, was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: dyskinesia. XANAX dosage: DAILY DOSE:1MG. During the same period patient was treated with DAKAR, ETANERCEPT, ZANTAC, CITALOPRAM HYDROBROMIDE, BISOPROLOL, YASMIN, DIHYDERGOT. Patient recovered.

XANAX problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 12, 2007. Female patient, 25 years of age, weighting 298.0 lb, was diagnosed with anxiety, depression and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: arthralgia. XANAX dosage: 1 MG 1X A DAY PO. During the same period patient was treated with ZOLOFT. Patient recovered.

Consumer or non-health professional from UNITED STATES reported XANAX problem on Sept 13, 2007. Male patient, weighting 115.0 lb, was diagnosed with cancer pain and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: feeling drunk, loss of consciousness, overdose, stupor. XANAX dosage: 0.5 MG 1 TAB T.I.D. PO. Patient died on 02/07/2006.

XANAX problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 12, 2007. Female patient, 46 years of age, was diagnosed with pain and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: loss of consciousness, overdose. XANAX dosage: unknown. During the same period patient was treated with DIAZEPAM, PERCOCET, OXYCONTIN. Patient died on 10/22/2002.

Physician from SLOVENIA reported XANAX problem on Sept 13, 2007. Female patient, 46 years of age, weighting 125.7 lb, was diagnosed with anxiety disorder and was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: intentional overdose, no adverse reaction. XANAX dosage: unknown. During the same period patient was treated with SEROQUEL, COAXIL. Patient recovered.

XANAX problem was reported by a Consumer or non-health professional from AUSTRALIA on Sept 19, 2007. Male patient, weighting 198.4 lb, was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: concussion, fall, road traffic accident. XANAX dosage: unknown. Patient recovered.

Health Professional from FRANCE reported XANAX problem on Sept 18, 2007. Male patient, 85 years of age, was treated with XANAX. After drug was administered, patient experienced the following problems/side effects: acidosis. XANAX dosage: unknown. During the same period patient was treated with BAMBUTEROL. Patient was hospitalized. Patient recovered.

< Previous  Showing 151-215 of 215

Ask Our Patient Community about XANAX

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert
(aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol

Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol

Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
Haloperidol
This drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant

Insulin Glulisine recombinant

Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
Linezolid
This drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant

Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus

PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa